Entering text into the input field will update the search result below

Zymeworks draws bullish view at Wells Fargo ahead of multiple catalysts

Oct. 04, 2022 2:24 PM ETZymeworks Inc. (ZYME) Stock, ZYME:CA StockAZN, DSKYF, DSNKY, BGNEBy: Dulan Lokuwithana, SA News Editor

Wall Street New York City

aluxum/E+ via Getty Images

Wells Fargo analyst James Shin and the team assumed coverage on cancer-focused biotech Zymeworks Inc. (NYSE:ZYME) with an Overweight recommendation Tuesday, noting a range of catalysts the Canadian company expects to generate over the next

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ZYME
--
ZYME:CA
--